EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of formulation on the pharmacokinetics and efficacy of doramectin


Veterinary Parasitology 49(1): 17-26
Effect of formulation on the pharmacokinetics and efficacy of doramectin
The pharmacokinetics of doramectin, a novel avermectin, were evaluated following parenteral administration in a range of oil-based formulations in an attempt to optimise the formulation. Therapeutic and persistent efficacies against Cooperia oncophora were also evaluated. This approach led to the identification of formulations based upon sesame oil and ethyl oleate which gave more prolonged doramectin plasma concentrations with no loss in therapeutic efficacy and improved persistent efficacy following subcutaneous administration to cattle at a dosage of 200 mu-g kg-1. The importance of using both pharmacokinetic and efficacy end points to distinguish between formulations is discussed. All formulations were well tolerated as evidenced by the absence of any reaction to injection either in the form of behavioural responses, injection site swelling or postmortem lesions. Sesame oil with ethyl oleate was the best parenteral vehicle tested for doramectin, allowing the expression of a high level of therapeutic and persistent efficacy and offering the benefit of excellent injection site toleration.

Accession: 002355991

PMID: 8236734

DOI: 10.1016/0304-4017(93)90219-d

Download PDF Full Text: Effect of formulation on the pharmacokinetics and efficacy of doramectin



Related references

Efficacy of a pour-on formulation of doramectin against lice, mites, and grubs of cattle. American Journal of Veterinary Research 60(4): 402-404, 1999

Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy. Journal of Controlled Release 150(2): 212-219, 2011

Persistence of the efficacy of a novel injectable ivermectin formulation and injectable doramectin against gastrointestinal nematodes in cattle. Veterinary Record 144(20): 564-565, 1999

Effect of route of administration on the efficacy and pharmacokinetics of an experimental formulation of the amino-acetonitrile derivative monepantel in sheep. Veterinary Record 166(16): 490-494, 2010

The effect of simulated rainfall on the efficacy of doramectin pour-on against nematode parasites of cattle. Veterinary Parasitology 86(4): 229-234, 1999

Pharmacokinetics, efficacy, tolerance of a new formulation of quinine in uncomplicated malaria in children. Methods & Findings in Experimental & Clinical Pharmacology 18(SUPPL B): 125, 1996

An inhaleable formulation of l dopa provides enhanced pharmacokinetics and superior efficacy in rat model of pd. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 326 1, 2002

Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan. Clinical Cancer Research 6(7): 2903-2912, 2000

Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation. Anticancer Research 25(1a): 331-341, 2005

Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone. Anticancer Research 21(5): 3313-3321, 2002